GlassScriptPhysician profile
Valdane Robinson
NPI 1245631241
$9,814.11
in general payments reported to CMS, 2019-2025
39 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,363 · 2022: $2,227 · 2023: $2,549 · 2024: $331 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,130 · Travel and Lodging: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,129.63 |
| Travel and Lodging | $1,094.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,971.12 | 2021-2025 | |
| Pacira Pharmaceuticals Incorporated | $1,292.68 | 2023 | Iovera, Exparel |
| Biohaven Pharmaceuticals, INC. | $1,199.33 | 2021 | |
| Novo Nordisk INC | $709.01 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $640.89 | 2021-2022 | |
| Lilly USA, LLC | $437.55 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $386.79 | 2023-2025 | Xtampza, Belbuca |
| Boehringer Ingelheim Pharmaceuticals, INC. | $310.09 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $305.53 | 2021-2022 | |
| Glaxosmithkline, LLC. | $248.64 | 2021-2022 | |
| Averitas Pharma INC. | $219.75 | 2023-2024 | Qutenza |
| Orexo US, INC. | $198.75 | 2023-2025 | Zubsolv |
| Grifols USA, LLC | $190.05 | 2021 | |
| Novartis Pharmaceuticals Corporation | $166.32 | 2022-2023 | |
| Pfizer INC. | $157.47 | 2021-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valdane Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.